content top

Secondary Angle Closure Glaucoma – An Unusual Complication of Polypoidal Choroidal Vasculopathy

Prabu Baskaran_SCIENTIFIC POSTER 2015 We report an unusual catastrophic complication of Polypoidal Choroidal Vasculopathy (PCV) despite an initial satisfactory response to treatment. A 67 year-old female presented to us in July 2012 with defective vision in RE since six months. She was a known hypertensive and diabetic on treatment since 15 years. There was no history of trauma, blood dyscrasias or use of any anticoagulants. On examination,...

Read More

Effects of Intravitreal Aflibercept on Patients with Polypoidal Choroidal Vasculopathy: Results of VAULT Study

Woohyok Chang_SCIENTIFIC POSTER 2015_2 Purpose: To investigate efficacy of intravitreal aflibercept injection in patients with treatment-naive polypoidal choroidal vasculopathy (PCV). Methods: A prospective, multi-center, single-arm, interventional case series conducted in South Korea. Forty seven patients with polypoidal choroidal vasculopathy (PCV) confirmed using indocyanine green (ICG) angiography were enrolled. Aflibercept (2.0 mg) was...

Read More

High Intensity Thermal Laser in Non-subfoveal Polypoidal Choroido Vasculopathy – An Effective Method

Advantages: In non-subfoveal idiopathic polypoidal choroido vasculopathy (IPCV) cases, the high to moderate intensity green laser along with or with out anti-vascular endothelial growth factor (anti-VEGF) injections may be tried with good success in cases refractory to photodynamic therapy (PDT). Methods: Five eyes of five patients were studied retrospectively. Two patients were male and three patients were female, the age group ranging...

Read More

Choroidal Vasculopathy Polipoydal. PTD guided by ICG. Long-term Period Results

Advantages: To evaluate the long-term outcome of patients suffering from symptomatic polypoidal choroidal vasculopathy (CVP), treated with focal photodynamic therapy (PDT), guided by indocyanine green (ICG). Methods: A prospective study of 11 eyes of 10 patients. Initially treated with focal PDT-VI guided. In 11 eyes the minimum follow up was 12 months, 9 eyes of 24 months, 7 to 36 months, 4 of 48 months and 3 to 60 months. We evaluated...

Read More

Role of Anti-VEGF Drugs in Therapeutic Approach to Idiopathic Polypoidal Choroidal Vasculopathy

García Alonso Ana, Fonollá Gil Marta, Castro Navarro Joaquín, González Castaño Carmen (Oviedo, Spain) Advantages: Idiopathic Polypoidal Choroidal Vasculopathy (IPCV) has distinctive features among the spectrum of Age-related Macular Degeneration (AMD), as is poor response to anti-VEGF monotherapy. When macular involvement is present, Photodynamic Therapy (PDT) has provided the best outcomes. Nevertheless, persistent subretinal fluid...

Read More

Intravitreal Ranibizumab Combined with Verteporfin Photodynamic Therapy for Treating Polypoidal Choroidal Vasculopathy

Jung Yeul Kim (Daejeon, South Korea) Purpose: To evaluate the efficacy of intravitreal ranibizumab (Lucentis) with verteporfin photodynamic therapy (PDT) for patients with polypoidal choroidal vasculopathy (PCV). Patients and Methods: Seventeen eyes of 17 patients with symptomatic PCV who received three monthly intravitreal ranibizumab injections with PDT were retrospectively reviewed. The follow-up period lasted over 6 months after...

Read More

How to Manage Polypoidal Choroidal Vasculopathy?

Authors: Isaac Alarcon, Daniel Vilaplana, Vladimir Poposki, Olga Martinez-Giralt, Miguel Castilla, Xenia Acebes, Barcelona, Spain Advantages / Purpose: Polypoidal choroidal vasculopathy is a disease with characteristic choroidal vascular abnormalities. Although the polypoidal choroidal vasculopathy and age-related macular degeneration have been known to share common genetic factors, its clinical characteristics suggest that polypoidal...

Read More

Photodynamic Therapy: Focal Treatment for Idiopathic Polypoidal Choroidal Vasculopathy

http://www.evrs.eu/medias/2008/congress/Photodynamic-Therapy:-Focal-Treatment-for-Idiopathic-Polypoidal-Choroidal-Vasculopathy.flv Daniel Vilaplana, Vladimir Poposki, Daniel Martin, Isaac Alarcon, Miguel Castilla Advantages: The focal (selective) treatment with photodynamic therapy (PDT) to treat idiopathic polypoidal choroidal vasculopathy (IPCV) has the advantage of producing minimum changes in the choroid and pigment...

Read More

Outcomes of Photodynamic Therapy for Idiopathic Polypoidal Choroidal Vasculopathy

Mun-Wai Lee, MD (Singapore, Singapore), Doric Wong, FRCS(Ed) (Singapore, Singapore) PURPOSE: To describe the efficacy of photodynamic therapy (PDT) in the treatment of idiopathic polypoidal choroidal vasculopathy (IPCV). METHODS: Retrospective analysis of a consecutive series of patients who presented with symptomatic serosanguineous maculopathy secondary to IPCV. All patients had indocyanine green defined lesions and underwent PDT with...

Read More

Clinical Characteristics of Exudative Age Related Macular Degeneration in Asian Patients

Gregg T. Kokame, MD (Honolulu, HI), Izumi Yamamoto, MD (Boston, MA) PURPOSE: To describe the clinical features of age-related macular degeneration (AMD) in Asian patients. METHODS: 14-year retrospective review of 203 eyes with choroidal neovascularization due to AMD or polypoidal choroidal vasculopathy (PCV) in 161 Asians in Hawaii. RESULTS: Etiology included AMD (91%) and PCV (9%). Location was subfoveal (78%), juxtafoveal (7%), or...

Read More

Current Management of Juxtapapilar Choroidal Neovascular (CNV) Lesions

Català Mora – Jaume, Jurgens Mestre – Ignasi Purpose: To evaluate the anatomic and functional results of three different approaches to juxtapapilar choroidal neovascular (CNV) lesions. Methods: Retrospective review of 10 consecutive eyes with juxtapapilar CNV treated with laser photocoagulation (3 cases), surgical extraction (3 cases) or observation (4 cases). Results: The average follow-up time was 12 months (6-24). Vision improved or...

Read More
content top